All In Biotech

Drug Trial Radar · NCT05843383

Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery

Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery in Elderly Patients Undergoing Laparoscopic Surgery

Last checked: Nov 19, 2026Latest source record: Apr 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

280

Planned (sponsor's estimate)

Start

May 16, 2023

Primary completion

Dec 1, 2024

Study completion Dec 1, 2024

Sponsor

Lead sponsor
Xijing HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Ciprofol is a novel 2,6-disubstituted phenol derivatives and is proved have much higher potency and tighter binding toward ɣ-aminobutyric acid type A (GABAA) receptor while maintaining a fast on-set and recovery time compared to propofol. Except lower incidence of hypotension and respiratory depression, it has no injection pain and infusion syndrome compared with propofol. There is no study to investigate overall postoperative functional recovery in patients receiving total intravenous anesthesia (TIVA) using ciprofol yet. However, according to study, early quality of recovery according to QoR-15 score is associated with one-month postoperative complications after elective surgery. Therefore, the purpose of this study is to determine whether there is any difference in the quality of postoperative recovery between ciprofol-based and propofol-based TIVA in elderly patients undergoing gastrointestinal surgery. The QoR-15 questionnaire score, pain, nausea/vomiting, and the frequency of complications are evaluated and compared between the two groups.

Conditions

  • Anesthetics, Intravenous
  • Postoperative Complications
  • Hypnotics and Sedatives
  • Postoperative Recovery

Interventions

  • CiprofolDrug

    Ciprofol group will be started and maintained total intravenous anesthesia with ciprofol and remifentanil

  • PropofolDrug

    Propofol group will be started and maintained total intravenous anesthesia with propofol and remifentanil

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quality of Recovery(QoR)-15 questionnaire score at postoperative day 1Time frame: Postoperative day 1

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Xijing Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • Xijing Hospital

    Xi'an, Shaanxi, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.